Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 15 INDUSTRY 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1

Interventions

Cisplatin 63 Paclitaxel 56 Carboplatin 38 Taxes 24 Radiotherapy 21 Gemcitabine 16 Brachytherapy 15 Filgrastim 14 Doxorubicin 13 Topotecan 12 Platinum 12 1,2-diaminocyclohexaneplatinum II citrate 12 Docetaxel 11 Radiation 7 Granulocyte Colony-Stimulating Factor 7 Chemotherapy, Adjuvant 7 pegfilgrastim 6 Surgical Procedures, Operative 6 Radiotherapy, Intensity-Modulated 6 Polymerase Chain Reaction 6 Ifosfamide 6 Etoposide 6 Watchful Waiting 5 Radiotherapy, Conformal 5 Pemetrexed 5 Gene Expression Profiling 5 Fluorouracil 5 Celecoxib 5 Amifostine 5 Observation 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × toripalimab × Gynecologic × Clear all

NCT04918186 2026-05-12

IPROC

Canadian Cancer Trials Group

Phase 2 Recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡